Business
AI summaryOrexo AB is a pharmaceutical company that provides advanced treatments for severe diseases and life-saving rescue medications in the United States, the European Union, the United Kingdom, and other markets. Its products include Zubsolv for opioid use disorder, Abstral for breakthrough cancer pain, Edluar for insomnia, and Diabact UBT for diagnosing Helicobacter pylori, while its pipeline features candidates for opioid and drug overdose, anaphylaxis, an intranasal semaglutide formulation built on its AmorphOX technology, and thermostable needle-free mucosal vaccines. The company was incorporated in 1994 and is headquartered in Uppsala, Sweden.
